Edwards Lifesciences Executive Selling Activity and Recent Financial Developments
The article details a recent transaction by Edwards Lifesciences Corporate Vice President, Daniel J. Lippis, who sold shares of common stock on May 18, 2026, following the exercise of employee stock options. This activity occurs against a backdrop of robust financial performance for the company in Q1 2026 and heightened positive sentiment from mult…